Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: An evidence update

Ontario Health Technology Assessment Series

Volumn 13, Issue 1, 2013, Pages 1-40

  Sehatzadeh, S ^a   Doble, B ^a   Xie, F ^a   Blackhouse, G ^a   Campbell, K ^a   Kaulback, K ^a   Chandra, K ^a   Goeree, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL EMBOLISM; ARTIFICIAL HEART PACEMAKER; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ENDOCARDITIS; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH ECONOMICS; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; LENGTH OF STAY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PACEMAKER; PATIENT SAFETY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SURGICAL APPROACH; SYSTEMATIC REVIEW (TOPIC); TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR DISEASE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; METHODOLOGY; REVIEW;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891720627     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sehatzadeh S, Doble B, Xie F, Blackhouse G, Campbell K, Kaulback K et al. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B) [Internet]. [updated 2012 May; cited 2012 Oct 1]. Available from: http://www.hqontario.ca/en/eds/tech/pdfs/2012/rev tavi may2012.pdf
2. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011 Mar;8(3): 162-172.
3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997 Mar 1;29(3):630-634.
4. Leggett M, Otto CM. Aortic valve disease. Curr Opin Cardiol. 1996 Mar;11(2): 120-125.
5. Zigelman CZ, Edelstein PM. Aortic valve stenosis. Anesthesiol Clin. 2009 Sep;27(3):519-532.
6. Anvari MS, Boroumand MA, Karimi A, lidoosti M, azdanifard P, hirzad M, et al. Aortic and mitral valve atherosclerosis: predictive factors and associations with coronary atherosclerosis using Gensini score. Arch Med Res. 2009 Feb;40(2): 124-127.
7. Otto CM, Mickel MC, Kennedy JW, Alderman EL, Bashore TM, Block PC, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994 Feb;89(2):642-650.
8. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007; 116(11 suppl):1240-1245.
9. Bonow RO, Carabello BA, Chatterjee K, de Leon ACJ, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006 Aug 1;48(3):e1-148.
10. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
11. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695.
12. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18): 1696-1704.
13. Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, et al. Health- related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (Cohort A). J Am Coll Cardiol. 2012;60(6):548-558.
14. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011; 124(18): 1964-1972.
15. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000 Apr;35(5):1245-1255.
16. Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res. 1999;8(1-2): 1-8.
17. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen (DK): The Nordic Cochrane Centre, The Cochrane Collaboration; 2011.
18. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011 Apr;64(4):380-382.
19. Goodman C. Literature searching and evidence interpretation for assessing health care practices. Stockholm, Sweden: Swedish Council on Technology Assessment in Health Care. 1996. 81p. SBU Report No. 119E.
20. Neyt M, Van BH. Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart. 2012 Jul;98(13): 1031-1033.